Shanafelt, T., Lanasa, M. C., Call, T. G., Beaven, A. W., Leis, J. F., LaPlant, B., . . . Zent, C. S. (2013). Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated CLL.
Styl cytowania ChicagoShanafelt, Tait, et al. Ofatumumab-based Chemoimmunotherapy Is Effective and Well Tolerated in Patients With Previously Untreated CLL. 2013.
Styl cytowania MLAShanafelt, Tait, et al. Ofatumumab-based Chemoimmunotherapy Is Effective and Well Tolerated in Patients With Previously Untreated CLL. 2013.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..